We are live on ! Find out more
OFM

Omega Fund Management Portfolio holdings

AUM $163M
1-Year Est. Return 107.06%
This Fund
S&P 500
This Quarter Est. Return
+44.78%
1 Year Est. Return
+107.06%
3 Year Est. Return
+111.75%
5 Year Est. Return
+84.24%
10 Year Est. Return
+495.59%
AUM
$217M
AUM Growth
–
Cap. Flow
+$170M
Cap. Flow %
78.14%
Top 10 Hldgs %
100%
Holding
7
New
7
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
JUNO
Juno Therapeutics, Inc.
JUNO
+$63.8M
2
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
+$51.1M
3
KYNB
Kyntra Bio
KYNB
+$25M
4
EGLT
Egalet Corporation
EGLT
+$15.4M
5
AKAO
Achaogen Inc
AKAO
+$6.68M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 58.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRTK
1
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$82.5M 37.93%
+2,138,872
New +$51.1M
JUNO
2
DELISTED
Juno Therapeutics, Inc.
JUNO
$74.4M 34.23%
+1,425,000
New +$63.8M
KYNB
3
Kyntra Bio
KYNB
$28.5M
$26.6M 12.23%
+38,887
New +$25M
EGLT
4
DELISTED
Egalet Corporation
EGLT
$15.1M 6.92%
+2,645,558
New +$15.4M
AKAO
5
DELISTED
Achaogen Inc
AKAO
$8.57M 3.94%
+656,899
New +$6.68M
DRNA
6
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$7.72M 3.55%
+468,471
New +$5.41M
TARA icon
7
Protara Therapeutics
TARA
$226M
$2.6M 1.2%
+6,250
New +$2.52M

Similar funds

HCCM
Hudson Canyon Capital Management New York $163M AUM 33.71% 1-Year Est. Return
PBO
Peoples Bank (Ohio) Marietta, Ohio $163M AUM 18.72% 1-Year Est. Return
PCR
Potrero Capital Research San Francisco, California $163M AUM 79.07% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $163M AUM 21.95% 1-Year Est. Return
IVGAI
Index Venture Growth Associates IV St. Helier, Jersey $163M AUM 54.88% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
TCGDR
TB Capital Gestao de Recursos Rio De Janeiro $163M AUM 20.86% 1-Year Est. Return
IPWA
International Private Wealth Advisors San Diego, California $163M AUM 16.99% 1-Year Est. Return

Omega Fund Management's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for Omega Fund Management, which disclosed 7 positions worth $217M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Juno Therapeutics, Inc.: 1,425,000 shares worth $74.4M.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets.

  • Omega Fund Management's largest Q4 2014 buy was Juno Therapeutics, Inc.: 1,425,000 shares worth $74.4M.
  • Omega Fund Management's ten largest holdings make up 100% of its $217M portfolio in Q4 2014.
  • Omega Fund Management disclosed 7 positions in Q4 2014, its first 13F filing on record.

Based on Omega Fund Management's 13F filing for Q4 2014, filed 23 Mar 2015.